— Know what they know.
Not Investment Advice
Also trades as: SNG.L (LSE) · $vol 0M

SYGGF OTC

Synairgen plc
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +900.0% 1Y: -50.0% 3Y: -99.9% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 46 · $110266 mcap · 170M float · 0.0054% daily turnover · Short 99% of daily vol

Cash Flow Trends

Operating Cash Flow
-$8M +5.0% ▲
Capital Expenditures
$94K -623.1% ▼
5Y CAGR: +56.5%
Free Cash Flow
-$8M +4.0% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$6M -10.2% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$18M-$58M-$20M-$8M-$7M
Depreciation & Amort.$260K$195K$102K$84K$33K
Stock-Based Comp.$207K$508K$919K$790K$419K
Change in Working Capital-$7M$12M-$4M$473K$82K
Other Non-Cash Items-$9K-$13K-$207K-$1M-$2M
Operating Cash Flow-$24M-$41M-$14M-$8M-$8M
— Investing Activities —
Capital Expenditures-$76K-$33K-$6K-$13K-$94K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0-$4M$0$0
Investment Sales$0$0$0$0$0
Other Investing$31K$12K$140K$3M$2M
Investing Cash Flow-$45K-$21K-$4M$3M$2M
— Financing Activities —
Net Debt Issuance-$196K-$124K$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$3M-$2K$0$0$13K
Financing Cash Flow$96M-$112K$1K$0$13K
Net Change in Cash$73M-$41M-$18M-$5M-$6M
Cash End of Period$75M$34M$16M$11M$5M
Free Cash Flow-$24M-$41M-$14M-$8M-$8M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms